Actor JK. Chapter 4 - T Lymphocytes: Ringleaders of adaptive immune function. In: Introductory Immunology: Basic Concepts for Interdisciplinary Applications. 3rd ed. Academic Press. February 2023.
Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25(1):20. Published 2018 Mar 6. doi:10.1186/s12929-018-0426-4
Babay W, Boujelbene N, Ben Yahia H, et al. Prognostic significance of high circulating sHLA-G in ovarian carcinoma. HLA. 2021;98(4):357-365. doi:10.1111/tan.14374
Brea EJ, Oh CY, Manchado E, et al. Kinase regulation of human MHC Class I molecule expression on cancer cells. Cancer Immunol Res. 2016;4(11):936-947. doi:10.1158/2326-6066.CIR-16-0177
Cruz-Tapias P, Castiblanco J, Anaya JM. Major histocompatibility complex: Antigen processing and presentation. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors.
Autoimmunity: From Bench to Bedside [Internet]. Bogota (Colombia): El Rosario University Press; 2013 Jul 18. Chapter 10. Accessed August 8, 2023.
https://www.ncbi.nlm.nih.gov/books/NBK459467/Di Tomaso T, Mazzoleni S, Wang E, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res. 2010;16(3):800-813. doi:10.1158/1078-0432.CCR-09-2730
Hazini A, Fisher K, Seymour L. Deregulation of HLA-I in cancer and its central importance for immunotherapy. J Immunother Cancer. 2021;9(8):e002899. doi:10.1136/jitc-2021-002899
JAMA Network Editors. AMA Manual of Style - A Guide for Authors and Editors. 11th ed. Oxford University Press. 2020.
Naranbhai V, Viard M, Dean M, et al. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Lancet Oncol. 2022;23(1):172-184. doi:10.1016/S1470-2045(21)00582-9
Pietra G, Manzini C, Vitale M, et al. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
Int Immunol. 2009;21(7):793-801. doi:10.1093/intimm/dxp047
Ran GH, Lin YQ, Tian L, et al. Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduct Target Ther. 2022;7(1):205. Published 2022 Jun 29. doi:10.1038/s41392-022-01058-z
Schaafsma E, Fugle CM, Wang X, Cheng C. Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy. Br J Cancer. 2021;125(3):422-432. doi:10.1038/s41416-021-01400-2
Sommer S. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool. 2005;2:16. Published 2005 Oct 20. doi:10.1186/1742-9994-2-16
Speed read: Seeking signs of compatibility. NobelPrize.org. Nobel Prize Outreach. Accessed August 8, 2023.
https://www.nobelprize.org/prizes/medicine/1980/speedread/Volonté A, Di Tomaso T, Spinelli M, et al. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4. J Immunol. 2014;192(1):523-532. doi:10.4049/jimmunol.1301342
Yeung JT, Hamilton RL, Ohnishi K, et al. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma. Clin Cancer Res. 2013;19(7):1816-1826. doi:10.1158/1078-0432.CCR-12-2861
Zamora AE, Crawford JC, Thomas PG. Hitting the target: How T cells detect and eliminate tumors. J Immunol. 2018;200(2):392-399. doi:10.4049/jimmunol.1701413
Note: All images (figures 1-5) used throughout this module were created by the author, Dr. Nancy Liu-Sullivan.
